Gastrointestinal disorders

Applied filters

Gastrointestinal disorders

Guidance (14)
- Administering (2)
- Cautions and contraindications (1)
- Excipients (1)
- Formulation (1)
- Prescribing (2)
- Safety in Breastfeeding (5)
- Safety in Pregnancy (3)
- Supply (2)
- Swallowing difficulties (1)
Medicine (15)
- Aluminium hydroxide (1)
- Alverine (1)
- Bisacodyl (1)
- Calcium carbonate (1)
- Calcium carbonate + Sodium alginate + Sodium bicarbonate (1)
- Cimetidine (1)
- Cinchocaine (1)
- Codeine (1)
- Cyclizine (1)
- Dicycloverine (1)
- Diltiazem (1)
- Docusate (1)
- Domperidone (1)
- Erythromycin (1)
- Esomeprazole (2)
- Famotidine (1)
- Glycerol (1)
- Glyceryl trinitrate (1)
- Golimumab (1)
- Hyoscine butylbromide (1)
- Hyoscine hydrobromide (1)
- Ispaghula husk (1)
- Lactulose (1)
- Lansoprazole (2)
- Lidocaine (1)
- Loperamide (1)
- Macrogol 3350 (1)
- Magnesium carbonate (1)
- Magnesium trisilicate (1)
- Mebeverine (1)
- Metoclopramide (2)
- Nizatidine (1)
- Omeprazole (2)
- Ondansetron (1)
- Pantoprazole (1)
- Peppermint oil (1)
- Prochlorperazine (1)
- Promethazine hydrochloride (1)
- Propantheline (1)
- Prucalopride (1)
- Rabeprazole (1)
- Senna (1)
- Sodium alginate + Magnesium alginate (1)
- Sodium bicarbonate (1)
- Sodium chloride (1)
- Sodium citrate (1)
- Sodium picosulfate (1)
- Thiamine (2)
- Ustekinumab (3)
- Zinc oxide (1)
Medicines planning (4)
- Biosimilars (4)
Specialty (20)
- Gastrointestinal disorders (20)
- Musculo-skeletal disorders (4)
- Nutritional and metabolic disorders (1)
- Skin disorders (3)
- Surgery (1)

Considerations for using medicines following bariatric surgery

30 May 2025Guidance on the physiological changes after bariatric surgery that can affect the pharmacokinetics of medicines and supplements.

Choosing a prokinetic medicine for impaired gastrointestinal motility

23 May 2025Prokinetics improve gastrointestinal motility. We advise on suitable prokinetic options, including dose and safety considerations.

Preparing to use golimumab biosimilar

21 May 2025Golimumab biosimilars are expected soon. We offer general information and implementation advice.

Haemorrhoids: treatment during pregnancy

4 March 2025Use non-pharmacological treatment for the management of haemorrhoids during pregnancy. If insufficient use a topical haemorrhoidal preparation.

Using loperamide in high output stoma or short bowel syndrome

7 November 2024This guidance explores the dosing and monitoring advice when using high dose loperamide to reduce high stoma output or in short bowel syndrome in adults.

Good governance when implementing ustekinumab biosimilar

2 August 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.

The licence and supporting evidence for ustekinumab biosimilars

2 August 2024Ustekinumab biosimilars (Pyzchiva, Steqeyma, Uzpruvo, Wezenla) are licensed. Learn about indications, formulations, supporting evidence and differences.

Preparing to use ustekinumab biosimilar

16 July 2024Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.

PPI suggestions for adults with swallowing difficulties

14 June 2024A range of proton pump inhibitor (PPI) formulations are suitable for adults with swallowing difficulties.

Using and prescribing thiamine in alcohol dependence

6 June 2024Intramuscular and intravenous thiamine can be used to prevent complications of alcohol dependence such as Wernicke’s encephalopathy.

SPS - Specialist Pharmacy Service

NHS